Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family

Oncogene

Volumn 14, Issue 15, 1997, Pages 1869-1874

  Lomax, M E ^a   Barnes, D M ^b   Gilchrist, R ^a   Picksley, S M ^c   Varley, J M ^d   Camplejohn, R S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Functional assays; Li Fraumeni syndrome; Oligomerisation domain; p53

Indexed keywords

AMINO ACID; ARGININE; CYSTEINE;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CODON; FAMILIAL CANCER; HUMAN; MISSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030926817     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201133     Document Type: Article

References (21)

1. Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, MacGeoch C, Spurr NK, Bartek J, Vojtesek B, Picksley SM and Lane DP. (1992). Lancet, 340, 259-263.
2. Bates S and Vousden KH. (1996). Curr. Opin. Gene. Dev., 6, 12-19.
3. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibanez-Koref MF. (1994). Cancer Res., 54, 1298-1304.
4. Camplejohn RS, Perry P, Hodgson SB, Turner G, Williams A, Upton C, MacGeoch C, Mohammed S and Barnes DM. (1995). Br J Cancer, 72, 654-662.
5. Cho Y, Gorina S, Jeffery PD and Pavletich NP. (1994). Science, 265, 346-355.
6. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
7. Eeles RA. (1995). Cancer Surv., 25, 101-124.
8. Flaman J-M, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher J-M, Bron L, Benhatter J, Tada M, Van Meir EG, Estreicher A and Iggo RD. (1995). Proc. Natl. Acad. Sci. USA, 92, 3963-3967.
9. Hainaut P, Hall A and Milner J. (1994). Oncogene, 9, 299-303.
10. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. (1996). Nucl. Acids Res., 24, 141-146.
11. Kastan MB, Canman CE and Leonard CJ. (1995). Cancer Metast. Rev., 14, 3-15.
12. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 251, 1708-1711.
13. Lane DP and Crawford LV. (1979). Nature, 278, 261-263.
14. Li FP, Fraumeni Jr JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW. (1988). Cancer Res., 48, 5358-5362.
15. Li FP and Fraumeni Jr JF. (1969). Ann. Intern. Med., 71, 747-752.
16. Linzer DH and Levine AJ. (1979). Cell, 17, 43-52.
17. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend SH. (1990). Science, 250, 1233-1238.
18. Picksley SM, Spicer JF, Barnes DM and Lane DP. (1996). Acta Oncologica, 35, 429-434.
19. Varley JM, McGown G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell ELD, Boyle J, Birch JM and Evans DGR. (1996). Oncogene, 12, 2437-2442.
20. Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD, Santibanez-Koref MF, Houlston RS, Martin, J, Birch JM and Evans DGR. (1995). J Med. Genet., 32, 942-945.
21. Wang P, Reed M, Wang Y, Mayr G, Stcnger JE, Anderson ME, Schwedes JF and Tegtmeyer P. (1994). Mol. Cell. Biol., 14, 5182-5191.